Literature DB >> 22100979

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Nancy Bunin1, Trudy Small, Paul Szabolcs, K Scott Baker, Michael A Pulsipher, Troy Torgerson.   

Abstract

Defective immune reconstitution is a major barrier to successful hematopoietic cell transplantation (HCT), and has important implications in the pediatric population. There are many factors that affect immune recovery, including stem cell source and graft-versus-host disease (GVHD). Complete assessment of immune recovery, including T and B lymphocyte evaluation, innate immunity, and response to neoantigens, may provide insight as to infection risk and optimal time for immunizations. The increasing use of cord blood grafts requires additional study regarding early reconstitution and impact upon survival. Immunization schedules may require modification based upon stem cell source and immune reconstitution, and this is of particular importance as many children have been incompletely immunized, or not at all, before school entry. Additional studies are needed in children post-HCT to evaluate the impact of differing stem cell sources upon immune reconstitution, infectious risks, and immunization responses.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22100979      PMCID: PMC3253930          DOI: 10.1016/j.bbmt.2011.11.014

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  81 in total

1.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-04-04

2.  Vaccination of hematopoietic cell transplant recipients.

Authors:  P Ljungman; C Cordonnier; H Einsele; J Englund; C M Machado; J Storek; T Small
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

3.  Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children.

Authors:  Cécile Rénard; Vincent Barlogis; Valérie Mialou; Claire Galambrun; Delphine Bernoux; Marie Pierre Goutagny; Laurence Glasman; Anderson Dieudonné Loundou; Françoise Poitevin-Later; Françoise Dignat-George; Valérie Dubois; Christophe Picard; Christian Chabannon; Yves Bertrand; Gérard Michel
Journal:  Br J Haematol       Date:  2010-12-07       Impact factor: 6.998

4.  A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.

Authors:  T Parkkali; R M Olander; T Ruutu; K Vuontela; L Volin; J Eskola; P Ruutu
Journal:  Bone Marrow Transplant       Date:  1997-05       Impact factor: 5.483

5.  Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT.

Authors:  T Parkkali; M Stenvik; T Ruutu; T Hovi; L Volin; P Ruutu
Journal:  Bone Marrow Transplant       Date:  1997-10       Impact factor: 5.483

6.  Varicella vaccination in children after bone marrow transplantation.

Authors:  A Sauerbrei; J Prager; U Hengst; F Zintl; P Wutzler
Journal:  Bone Marrow Transplant       Date:  1997-09       Impact factor: 5.483

7.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors.

Authors:  P Rubinstein; C Carrier; A Scaradavou; J Kurtzberg; J Adamson; A R Migliaccio; R L Berkowitz; M Cabbad; N L Dobrila; P E Taylor; R E Rosenfield; C E Stevens
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

8.  Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells.

Authors:  Lloyd J D'Orsogna; Matthew P Wright; Rom G Krueger; Elizabeth J McKinnon; Susan I Buffery; Campbell S Witt; Nicole Staples; Richard Loh; Paul K Cannell; Frank T Christiansen; Martyn A French
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

9.  Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation.

Authors:  Trudy N Small; Andrew D Zelenetz; Ariela Noy; R David Rice; Tanya M Trippett; Lauren Abrey; Carol S Portlock; Emily J McCullagh; Jill M Vanak; Ann Marie Mulligan; Craig H Moskowitz
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-25       Impact factor: 5.742

10.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey S Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

View more
  12 in total

1.  Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.

Authors:  Rudolph Kirk R Schultz; Kevin Scott Baker; Jaap J Boelens; Catherine M Bollard; R Maarten Egeler; Mort Cowan; Ruth Ladenstein; Arjan Lankester; Franco Locatelli; Anita Lawitschka; John E Levine; Mignon Loh; Eneida Nemecek; Charlotte Niemeyer; Vinod K Prasad; Vanderson Rocha; Shalini Shenoy; Brigitte Strahm; Paul Veys; Donna Wall; Peter Bader; Stephan A Grupp; Michael A Pulsipher; Christina Peters
Journal:  Biol Blood Marrow Transplant       Date:  2013-07-21       Impact factor: 5.742

2.  GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Authors:  Jiusheng Deng; Yanqiu Li; Andrea Pennati; Shala Yuan; Jian Hui Wu; Edmund K Waller; Jacques Galipeau
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 3.  The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.

Authors:  Andrew C Dietz; Christine N Duncan; Blanche P Alter; Dorine Bresters; Morton J Cowan; Luigi Notarangelo; Philip S Rosenberg; Shalini Shenoy; Roderick Skinner; Mark C Walters; John Wagner; K Scott Baker; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-11       Impact factor: 5.742

Review 4.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Jennifer Puck; Rebecca Buckley; Thomas A Fleisher; Andrew R Gennery; Benedicte Neven; Mary Slatter; Elie Haddad; Luigi D Notarangelo; K Scott Baker; Andrew C Dietz; Christine Duncan; Michael A Pulsipher; Mort J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-06       Impact factor: 5.742

5.  National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.

Authors:  Michael A Pulsipher; Roderick Skinner; George B McDonald; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Clarisa Gracia; Anna Petryk; Smita Bhatia; Nancy Bunin; Michael L Nieder; Christopher C Dvorak; Lillian Sung; Jean E Sanders; Joanne Kurtzberg; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2012-01-14       Impact factor: 5.742

6.  Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors.

Authors:  Eric J Chow; Kara L Cushing-Haugen; Guang-Shing Cheng; Michael Boeckh; Nandita Khera; Stephanie J Lee; Wendy M Leisenring; Paul J Martin; Beth A Mueller; Stephen M Schwartz; K Scott Baker
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

Review 7.  Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Rebecca H Buckley; Jennifer Puck; Thomas A Fleisher; Andrew R Gennery; Elie Haddad; Benedicte Neven; Mary Slatter; Skinner Roderick; K Scott Baker; Andrew C Dietz; Christine Duncan; Linda M Griffith; Luigi Notarangelo; Michael A Pulsipher; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-04       Impact factor: 5.742

Review 8.  Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia.

Authors:  Anita Lawitschka; Christina Peters
Journal:  Curr Oncol Rep       Date:  2018-08-03       Impact factor: 5.075

9.  Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation.

Authors:  Julie Lang; Margot Kelly; Brian M Freed; Martin D McCarter; Ross M Kedl; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2013-01-18       Impact factor: 5.422

Review 10.  Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Authors:  Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.